Abbott/Kos’ Integrated Sales Force Expected To Accelerate Niaspan Growth
Abbott says there will be “synergistic” effects from folding Niaspan into its cholesterol portfolio that will improve sales over those seen when Kos was the sole marketer.
Abbott says there will be “synergistic” effects from folding Niaspan into its cholesterol portfolio that will improve sales over those seen when Kos was the sole marketer.